As new PrEP products move out of clinical trials and toward market entry, implementation research has a pivotal role to play in guiding the introduction and scale-up of these new products in real-world service delivery settings.
Continue Reading
Category: Research
CONFERENCE REFLECTIONS: TWO CROI “ROOKIES” DRAW INSPIRATION FROM CROI AT 30
CROI is a forum for scientists and clinical investigators to present, discuss, and critique their investigations into the epidemiology and biology of human retroviruses and associated diseases, including HIV and AIDS. It was the 30th year of the conference, but our first time attending. In this post, we reflect on what we learned and how we might apply key takeaways to our work on MOSAIC.
Continue Reading
A NEW OPTION TO TRANSFORM HIV PREVENTION
The future of HIV prevention is here. Injectable cabotegravir (CAB) is the most effective, longest-acting option for avoiding the virus. Until now, pre-exposure prophylaxis (or PrEP) medicine taken to prevent HIV has only been available as an oral pill that must be taken daily. CAB needs to be injected only once every two months.
Continue Reading
AIDS 2022 SCIENTIFIC WORKSHOP | OUR NEXT SHOT: EFFECTIVELY DELIVERING INJECTABLE CABOTEGRAVIR FOR PrEP
This workshop will explore what is needed to ensure that introductory research and programs are strategically designed, user-centered, and appropriately resourced to support successful rollout of CAB PrEP.
Continue Reading
AFRICANS LEADING RESEARCH EFFORT TO CONTROL HIV AND COVID-19 IN AFRICA: INTEREST 2022
Sub-Saharan Africa is home to 25.3 million (67%) of the global total of 37.7 million people living with HIV infection (UNAIDS 2021). To control the epidemic in Africa, it is essential that solutions for Africa be generated and implemented in Africa.
Continue Reading
TURNING HIV PREVENTION RESEARCH INTO REALITY FOR ADOLESCENT GIRLS AND YOUNG WOMEN IN AFRICA
With the dapivirine vaginal ring and injectable cabotegravir poised to join oral pre-exposure prophylaxis (PrEP) as safe, effective HIV prevention products, people seeking an HIV prevention method that works for them will soon have real choices.
Continue Reading
NOVEL HIV PREVENTION PRODUCTS: EXPANDING THE EVIDENCE FOR INTRODUCTION
When countries introduce novel HIV prevention products, such as the PrEP ring and injectable CAB PrEP, how will women decide which product to use, and what will influence those decisions?
Continue Reading
“THESE NEW PRODUCTS GIVE ME POWER AND CONTROL OVER MY LIFE AND HEALTH”: CELEBRATING CHOICE ON INTERNATIONAL WOMEN’S DAY
Today, we observe International Women’s Day, a day to celebrate the many achievements of women around the globe.
Continue Reading
WHAT’S NEXT FOR CAB PrEP?
In this webinar, we explore ongoing and completed research on CAB PrEP, learn about the recently released FDA guidance, and hear from a panel of implementers and policymakers on what is needed to advance introduction of this new HIV prevention product.
Continue Reading